Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately Post author:Sam Post published:November 15, 2017 Post category:BioPharma The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace You Might Also Like Horizon Pharma Pays $145 Million For And Its Rare Eye Disease Drug May 7, 2017 NeuroDerm Announces Extraordinary General Meeting Of Shareholders January 26, 2017 Illumina Reports Full Financial Results For Fourth Quarter And Fiscal Year 2016 January 31, 2017